
Humanities vital to improving Australian healthcare
The humanities aren’t fluffy, but essential, if Australia wants maximum return on our investment in healthcare and medical research. Can you name the Australian health researcher who has saved the
The humanities aren’t fluffy, but essential, if Australia wants maximum return on our investment in healthcare and medical research. Can you name the Australian health researcher who has saved the
Clinical trials and preventative healthcare programs worth millions of dollars in research funding have collapsed due to a lack of participation during the COVID-19 pandemic. Programs, such as those targeting
There are conversations that shouldn’t take place around the table at Christmas. But one, perhaps, should: your wishes for the end of your life. It could be one of the
Safety giant Shojania wrote this editorial to accompany a study where predictive risk stratification was introduced into primary care in order to help Welsh GPs make preventative plans for patients
Oliver, K., Kothari, A. & Mays, N. The dark side of coproduction: do the costs outweigh the benefits for health research?. Health Res Policy Sys 17, 33 (2019). https://doi.org/10.1186/s12961-019-0432-3 This paper was a
We are thrilled to see $218 million will be invested in Australia’s translational health research centres as part of the Federal Government’s 2019-2020 Budget. The money, to be provided over
The NSW Regional Health Partners currently have an expression of interest open for Health Research Translation in the area of End of Life. You can submit your application here. In
During early 2019 the NSW Regional Health Partners will run two Expression of Interest processes: Health Research Translation in the area of End of Life. A survey on End of
The Consumers Health Forum (CHF) of Australia released a white paper in November 2018 ‘Shifting Gears, Consumers transforming health’. It describes the risk of a chasm between policy intent to
In 2018, UK Innovation Foundation NESTA commissioned a report by Richard Jones and James Wilsdon entitled ‘The Biomedical Bubble’. It argues for more diversity in UK research, the ‘biomedical bubble’